InsidersTradesSigma
Discover the full directors' dealings record of Arbutus Biopharma Corporation, a listed issuer based in Canada. Shares are quoted on CA CA, under the oversight of SEDI. The latest transaction was disclosed on 11 June 2026 (50 - Grant of options). Among the most active insiders: Sawhney, Roger. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations